drugset / Trial / NCT02628626
A Study of Colesevelam in Fecal Incontinence
Phase 3
Completed
88 enrolled
Mayo Clinic
National Center for Research Resources (NCRR) · collabNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Compare the effects of a combination of colesevelam and clonidine to placebo on bowel symptoms in patients with urge or combined type of FI.
Timeline
- Start
- 2015-11
- Primary completion
- 2022-04-14
- Completion
- 2022-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clonidine | Other / unclassified | 0.1 mg | Oral |
| Comparator | Colesevelam | Other / unclassified | 1.875 g | — |